Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 3
1976 1
1977 1
1978 1
1980 1
1981 2
1983 3
1984 2
1985 2
1986 3
1987 1
1988 1
1989 3
1990 5
1991 7
1992 1
1993 1
1994 2
1995 5
1996 4
1997 3
1998 4
1999 3
2000 6
2001 2
2002 6
2003 1
2004 6
2006 10
2007 7
2008 9
2010 7
2011 1
2012 7
2013 4
2014 7
2015 7
2016 6
2017 6
2018 17
2019 8
2020 14
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

182 results
Results by year
Filters applied: . Clear all
Page 1
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.
Kim D, Robertson JS, Excler JL, Condit RC, Fast PE, Gurwith M, Pavlakis G, Monath TP, Smith J, Wood D, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Kim D, et al. Among authors: condit rc. Vaccine. 2020 Jul 22;38(34):5556-5561. doi: 10.1016/j.vaccine.2020.06.017. Epub 2020 Jun 19. Vaccine. 2020. PMID: 32571717 Free PMC article. Review.
Demographic trade-offs predict tropical forest dynamics.
Rüger N, Condit R, Dent DH, DeWalt SJ, Hubbell SP, Lichstein JW, Lopez OR, Wirth C, Farrior CE. Rüger N, et al. Among authors: condit r. Science. 2020 Apr 10;368(6487):165-168. doi: 10.1126/science.aaz4797. Science. 2020. PMID: 32273463
Biodiversity recovery of Neotropical secondary forests.
Rozendaal DMA, Bongers F, Aide TM, Alvarez-Dávila E, Ascarrunz N, Balvanera P, Becknell JM, Bentos TV, Brancalion PHS, Cabral GAL, Calvo-Rodriguez S, Chave J, César RG, Chazdon RL, Condit R, Dallinga JS, de Almeida-Cortez JS, de Jong B, de Oliveira A, Denslow JS, Dent DH, DeWalt SJ, Dupuy JM, Durán SM, Dutrieux LP, Espírito-Santo MM, Fandino MC, Fernandes GW, Finegan B, García H, Gonzalez N, Moser VG, Hall JS, Hernández-Stefanoni JL, Hubbell S, Jakovac CC, Hernández AJ, Junqueira AB, Kennard D, Larpin D, Letcher SG, Licona JC, Lebrija-Trejos E, Marín-Spiotta E, Martínez-Ramos M, Massoca PES, Meave JA, Mesquita RCG, Mora F, Müller SC, Muñoz R, de Oliveira Neto SN, Norden N, Nunes YRF, Ochoa-Gaona S, Ortiz-Malavassi E, Ostertag R, Peña-Claros M, Pérez-García EA, Piotto D, Powers JS, Aguilar-Cano J, Rodriguez-Buritica S, Rodríguez-Velázquez J, Romero-Romero MA, Ruíz J, Sanchez-Azofeifa A, de Almeida AS, Silver WL, Schwartz NB, Thomas WW, Toledo M, Uriarte M, de Sá Sampaio EV, van Breugel M, van der Wal H, Martins SV, Veloso MDM, Vester HFM, Vicentini A, Vieira ICG, Villa P, Williamson GB, Zanini KJ, Zimmerman J, Poorter L. Rozendaal DMA, et al. Among authors: condit r. Sci Adv. 2019 Mar 6;5(3):eaau3114. doi: 10.1126/sciadv.aau3114. eCollection 2019 Mar. Sci Adv. 2019. PMID: 30854424 Free PMC article.
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.
Kochhar S, Kim D, Excler JL, Condit RC, Robertson JS, Drew S, Whelan M, Wood D, Fast PE, Gurwith M, Klug B, Khuri-Bulos N, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Kochhar S, et al. Among authors: condit rc. Vaccine. 2020 Jul 31;38(35):5734-5739. doi: 10.1016/j.vaccine.2020.06.044. Epub 2020 Jul 9. Vaccine. 2020. PMID: 32653276 Free PMC article. Review.
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines.
Condit RC, Kim D, Robertson JS, Excler JL, Gurwith M, Monath TP, Pavlakis G, Fast PE, Smith J, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Benefit-Risk Assessment of Vaccines by Technology (BRAVATO) Working Group. Electronic address: bc-coordinator@taskforce.org. Condit RC, et al. Vaccine. 2020 Nov 17;38(49):7708-7715. doi: 10.1016/j.vaccine.2020.08.009. Epub 2020 Sep 6. Vaccine. 2020. PMID: 32907759 Free PMC article. Review.
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
Gurwith M, Condit RC, Excler JL, Robertson JS, Kim D, Fast PE, Drew S, Wood D, Klug B, Whelan M, Mallett Moore T, Khuri-Bulos N, Smith ER, Chen RT, Kochhar S; Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG. Gurwith M, et al. Among authors: condit rc. Vaccine. 2020 Nov 17;38(49):7702-7707. doi: 10.1016/j.vaccine.2020.09.042. Epub 2020 Oct 16. Vaccine. 2020. PMID: 33070999 Free PMC article. Review.
The interspecific growth-mortality trade-off is not a general framework for tropical forest community structure.
Russo SE, McMahon SM, Detto M, Ledder G, Wright SJ, Condit RS, Davies SJ, Ashton PS, Bunyavejchewin S, Chang-Yang CH, Ediriweera S, Ewango CEN, Fletcher C, Foster RB, Gunatilleke CVS, Gunatilleke IAUN, Hart T, Hsieh CF, Hubbell SP, Itoh A, Kassim AR, Leong YT, Lin YC, Makana JR, Mohamad MB, Ong P, Sugiyama A, Sun IF, Tan S, Thompson J, Yamakura T, Yap SL, Zimmerman JK. Russo SE, et al. Among authors: condit rs. Nat Ecol Evol. 2021 Feb;5(2):174-183. doi: 10.1038/s41559-020-01340-9. Epub 2020 Nov 16. Nat Ecol Evol. 2021. PMID: 33199870
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
Kochhar S, Excler JL, Kim D, Robertson JS, Fast PE, Condit RC, Drew S, Wood D, Gurwith M, Klug B, Whelan M, Khuri-Bulos N, Mallett Moore T, Smith ER, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG). Electronic address: brightoncollaborationv3swg@gmail.com. Kochhar S, et al. Among authors: condit rc. Vaccine. 2020 Sep 3;38(39):6184-6189. doi: 10.1016/j.vaccine.2020.07.028. Epub 2020 Jul 31. Vaccine. 2020. PMID: 32747214 Free PMC article.
182 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page